期刊文献+

姜黄素缓释胶束的制备、表征及其抗细胞毒类药物的多药耐药性评价 被引量:6

Polymeric Micelles for Sustained Release of Curcumin:Preparation,Characterization and in vivo Evaluation of Overcoming Multidurg Resistance for Cytotoxic Drugs
下载PDF
导出
摘要 姜黄素为传统中药姜黄中提取的多酚类化合物,具有多靶点的抗肿瘤活性及确切的抗炎和抗氧化等作用。但姜黄素几乎不溶于水,口服不吸收,且存在严重的肝首过效应,因此系统生物利用度很低,难以充分发挥其抗肿瘤活性。合成了叔丁氧羰基苯丙氨酸封端的甲氧基聚乙二醇-聚己内酯嵌段共聚物,并采用固体分散工艺制备了可注射给药的姜黄素共聚物胶束,结果表明:胶束在体内具有良好的稳定性和缓释效果,能显著减缓姜黄素在体内的代谢速度,从而提高生物利用度;该胶束和阿霉素联用不仅能提高药效,还能有效降低阿霉素的毒性,具有良好的临床应用前景。 Curcumin, a polyphenolic natural extract of curcuma longa, exhibits a wide range of pharmacological influence including anti-oxidant, anti-inflammatory, and anti-tumor activities in various preclinical models. However, the low systemic bioavailability of curcumin is also highlighted, which has been mainly attributed to its extremely low aquous solubility and severe liver first pass effect. In the present study, N-t-butoxycarbonyl- phenylalanine (Boc-Phe) terminated monomethoxyl poly (ethylene glycol)-b-poly(ε-caprolactone) block copolymer (mPEG-PCL-Phe(Boc)) was synthesized and characterized by 1H-NMR and gel permeation chromatography. The curcumin-loaded mPEG-PCL-Phe(Boc) micelles were prepared by a solid dispersion method and showed significant improved stability in plasma compared with free curcumin upon parenteral administration. So the internal metabolism velcocity of curcumin was slow down and the bioavailabity was improved. The combination of parenteral curcumin micelle with doxorubicin resulted in enhanced tumor growth inhibition versus either single agent. Furthermore, a simultaneous decrease in doxorubicin-induced systemic toxicity by curcumin-loaded micelle was also observed. Overall, curcumin-loaded micelle is a promising new formulation that is able to enhance the efficacy of chemotherapeutic drugs and combat multi-drug resistance.
出处 《华东理工大学学报(自然科学版)》 CAS CSCD 北大核心 2014年第5期562-567,共6页 Journal of East China University of Science and Technology
基金 "重大新药创制"国家科技重大专项(2014ZX09301-306-06)
关键词 姜黄素 胶束 生物利用度 多药耐药 curcumin; micelle; bioavailability; multi-drug resistance
  • 相关文献

参考文献9

  • 1Misra R, Sahoo S K. Coformulation of doxorubicin and curcu- min in poly(D,L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells[J]. Molecular Pharmaceutics, 2011, 8(3): 852-866.
  • 2Dipankar P A. Composite polymer nanopartiele overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy[J]. Oncotarget, 2012, 3(6) : 640-650.
  • 3Heger M, van Golen R F, Broekgaarden M, etal. The molec- ular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites inrelation to cancers[J]. Pharma- cological Reviews, 2014, 66(1) : 222-307.
  • 4Goel A, Kunnumakkara A B, Aggarwal B B. Curcumin as "Cureeumin':From kitchen to clinic[J]. Biochemical Pharma- cology, 2008, 75(4): 787-809.
  • 5Anand P, Kunnumakkara A B, Newman R A, etal. Bioavail- ability of cureumin: Problems and promises[J]. Molecular Pharmaceutics, 2007, 4(6) : 807-818.
  • 6Dhillon N, Aggarwal B B, Newman R A, etal. Phase II trial of curcumin in patients with advanced pancreatic eancer[J]. Clinical Cancer Research, 2008, 14: 4491-4499.
  • 7Fan Yujiang, Chen Guoping, Tanaka J, et al. L-Phe end- capped poly (L-lactide) as macroinitiator for the synthesis of poly ( L-lactide)-b-poly (L-lysine) block copolymer [ J]. Bio- macromolecules, 2005, 6(6): 3051-3056.
  • 8Kang N, Leroux J C. Triblock and star-block copolymers of N-(2-hydroxypropyl) methacrylamide or N-vinyl-2-pyrroli- done and D,L-lactide: Synthesis and self-assembling properties in water[J]. Polymer, 2004, 45(26): 8967-8980.
  • 9Song Zhimei, Feng Runliang, Sun Min, et al. Curcumin-load- ed PLGA-PEG-PLGA triblock copolymerie micelles: Prepara- tion, pharmacokinetles and distribution in vlvo[J]. Journal of Colloid and Interface Science, 2011, 354(1).. 116-123.

同被引文献47

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部